Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages

News

News

News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors

Welcome to epgonline.org - the website for healthcare professionals

What's new? The Bedwetting Knowledge Centre

Bedwetting, or nocturnal enuresis is defined as intermittent incontinence while sleeping. Applicable to children ≥ 5 years old, wetting episodes of any type that occur in discrete amounts are indicative to nocturnal enuresis.1,2

Due to variations in comorbidity, treatment response and pathogenesis, nocturnal enuresis can be divided into two subgroups – monosymptomatic nocturnal enuresis (MNE) and non-monosymptomatic nocturnal enuresis (NMNE).1,3 Absence of lower urinary tract symptoms or a history of bladder dysfunction is characteristic of MNE, while NMNE is defined as nocturnal enuresis accompanied by daytime urinary symptoms.

Nocturnal enuresis can have a profound impact on the child and their family, lowering a child’s self image, causing behavioural problems and affecting school performance. However, successful treatment improves the mental health of the child and brings practical relief to the family.

Latest News

Cubist Pharma files combination ceftolozane + tazobactam at FDA for Urinary Tract and Intra-Abdominal Infections.

22-Apr-2014

Cubist Pharmaceuticals, Inc. has ...

Supreme Court rejects Teva's attempt to prevent launch of generic Copaxone

22-Apr-2014

Mylan Inc. has announced that ...

Aastrom Bioscience acquires Sanofi's Cell Therapy and Regenerative Medicine business for $6.5 million

22-Apr-2014

Aastrom Biosciences, Inc. the leading ...

Pfizer makes offer for AstraZeneca

22-Apr-2014

It is reported that Pfizer has offered ...

UK will fund Sovaldi for patients with acute liver failure or those awaiting transplantation- Gilead

19-Apr-2014

The NHS England’s Clinical ...

FDA approves Arzerra combination therapy for CLL-GSK/Genmab

19-Apr-2014

The FDA has approved a Supplemental ...

FDA approves Ragwitek for treating Ragweed-induced Allergy - Merck

19-Apr-2014

The FDA has approved Ragwitek (Short ...

Recent Updates

Drugs

Clinical Guidelines

Alcohol use disorders: diagnosis and clinical management of alcohol-related physical complications

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

European Psychiatric Association (EPA) guidance on prevention of mental disorders

Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease

Medical Journals

Development and evaluation of an automatic acne lesion detection program using digital image processing

Short-acting ?-agonist use and its ability to predict future asthma-related outcomes

Cytomegalovirus infection post-pancreas–kidney transplantation – results of antiviral prophylaxis in high-risk patients

Analysis of sentinel lymph node positivity in patients with thin primary melanoma

epgonline.org Social